Abstract
Barrett’s esophagus is a pathological entity in which the normal squamous mucosa of the lower esophagus is replaced by a metaplastic columnar mucosa. It is accepted to be a consequence of gastro-esophageal reflux disease (GERD) and is premalignant. It has been suggested that in health the normal distal esophagus may be lined by columnar mucosa for a distance of up to 2 cm,1 placing the squamocolumnar junction within the lower esophagus. In clinical practice the landmarks which define the exact termination of the esophagus and the beginning of the stomach have proved difficult to measure with certainty, especially in patients with a hiatus hernia. Consequently, Barrett’s esophagus, was previously only diagnosed when the columnar mucosa extended well into the esophagus, at least 3 cm proximal to the gastro-esophageal junction2. Other investigators have used different criteria ranging from 2 to 5cm3’4. However in the 1980s the accepted international standard for the diagnosis of Barrett’s esophagus was a purely endoscopic diagnosis, made when the squamo-columnar junction (SCJ) was located more than 3cm above the proximal gastric folds.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Hayward J. The lower end of the esophagus. Thorax 1961; 16: 36–41.
SkinnerDB, Walther BC, Riddell RI-1 et al. Barrett’s esophagus:Comparison of benign and malignant cases. Ann Surg 1983; 198: 554–65.
McClave SA, Boyce I-1W Jr, Gottfried MR. Early diagnosis of columnar-lined oesophagus:a new endoscopie criterion. Gastrointest Endosc 1987; 33: 413–6.
Rothery GA, Patterson JE, Stoddard CJ, Day DW. Histological and histochemical changes in the columnar lined (Barrett’s) oesophagus. Gut 1986; 27: 1062–8.
Paull A, Trier JS, Dalton MD, et al. The histological spectrum of Barrett’s esophagus. N Engl J Med 1971; 295: 476–80.
Reid BJ, Haggitt RC, Rubin CE, Rabinovitch PS. Barrett’s esophagus. Correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma. Gastroenterol 1987; 93: 111.
Schnell TG, Sontag Si, Chejfec G. Adenocarcinomas arising in tongues or short segments of Barrett’s esophagus. Dig Dis Sci 1992; 37: 137–43.
Johnston MH, Hammond AS, Laskin W, Jones DM. The prevalence and clinical characteristics of short segments of specialized intestinal metaplasia in the distal esophagus on routine endoscopy. Am J Gastroenterol 1996; 91: 1507–11.
Clark GWB, Ireland AP, Peters JH, Chandrasoma P, DeMeester TR, Bremner CG. Short-segment Barrett’s esophagus:a prevalent complication of gastro-esophageal reflux disease with malignant potential. J Gastrointest Surg 1997; 1: 113–22.
Weston AP, Krmpotich P, Makdisi WF et al. Short segment Barrett’s esophagus:clinical and histological features, associated endoscopie findings, and association with gastric intestinal metaplasia. Am J Gastroenterol 1996; 91: 981–6.
Nandurkar S, Talley NJ, Martin CJ, Ng THK, Adams S. Short segment Barrett’s oesophagus:prevalence, diagnosis and associations. Gut 1997; 40: 710–5.
Clark GWB, Ireland AP, Chandrasoma P, DeMeester TR, Peters JH, Bremner CG. Inflammation and metaplasia in the transitional epithelium of the gastroesophageal junction:A new marker for gastroesophageal reflux disease. Gastroenterol 1994; 106: A63.
Spechler SJ, Zeroogian JM, Antonioli DA, Wang HH, Goya! RK. Prevalence of metaplasia at the gastro-oesophageal junction. Lancet 1994; 344: 15336.
Cameron AJ, Lomboy CT. Barrett’s esophagus:age, prevalence, and extent of columnar epithelium. Gastroenterol 1992; 103: 1241–5.
GOSPE (Gruppo Operativo per to Studio delle Precancerosi dell’Esofago). Barrett’s esophagus:epidemiological and clinical results of a multicentric survey. Int J Cancer 1991; 48: 364–8.
Cameron AJ, Zinsmeister AR, Ballard DJ, Carney JA. Prevalence of columnar-lined (Barrett’s) esophagus. Comparison of population based clinical and autopsy findings. Gastroenterol 1990; 99: 918–22.
Iascone C, DeMeester TR, Little AG, Skinner DB. Barrett’s esophagus. Functionalassessment, proposed pathogenesis and surgical therapy. Arch Surg 1983; 118: 543–9.
Attwood SEA, DeMeester TR, Bremner CG, Barlow AP, Hinder RA. Alkaline gastro-esophageal reflux: Implications in the development of complications in Barrett’s columnar-lined lower esophagus. Surgery 1989; 106: 764–70.
Champion G. Richter JE. Vaezi MF. Singh S. Alexander R. Duodenogastro-esophageal reflux:relationship to pH and importance in Barrett’s esophagus. Gastroenterol 1994; 107: 747–54.
Kauer WKH, Peters JH, DeMeester TR et al. Mixed reflux of gastric and duodenal juice is more harmful to the esophagus than gastric juice alone. The need for surgical therapy re-emphasized. Ann Surg 1995; 222: 525–33.
Iftikhar SY, James PD, Steele RJC, Hardcastle JD, Atkinson M. Length of Barrett’s oesophagus:an important factor in the development of dysplasia and adenocarcinoma. Gut 1992; 33: 1155–8.
Reid BJ. Barrett’s esophagus and esophageal adenocarcinoma. Gastroenterol Clin N Am 1991; 20: 817–34.
McCallum R.W., Polepalle S., Davenport K., Frierson H., Boyd S. Role of anti-reflux surgery against dysplasia in Barrett’s esophagus. Gastroenterol 1991;100::Al21.
Ortiz A, Martinez de Haro LF, Parrilla P et al. Conservative treatment versus antiretlux surgery in Barrett’s oesophagus:long-term results of a prospective study. Br J Surg 1996; 83: 274–8.
McDonald ML, Trastek VF, Allen MS, et al. Barretts’s esophagus:does an antireflux procedure reduce the need for endoscopie surveillance? J Thorac and Cardiovasc Surg 1996; 111: 1135–8.
Byrne JP, Bhatnagar S, Hamid B, Armstrong GR, Attwood SEA. Comparative study of intestinal metaplasia and mucin staining at the cardia and esophagogastric junction in 225 symptomatic patients presenting for diagnostic open-access gastroscopy. Am J Gastroenterol 1999; 94: 98–103.
Winters C Jr, Spurling TJ, Chobanian SJ et al. Barrett’s oesophagus. A prevalent, occult complication of gastro-esophageal reflux disease. Gastroenterology 1987; 92: 118–24.
Loughney T, Maydonovitch CL, Wong RKH. Esophageal manometry and ambulatory 24-hour pH monitoring in patients with short and long segment Barrett’s esophagus. Am J Gastrenterol 1998; 93: 916–9.
Stein HJ, Siewert JR. Barrett’s esophagus:pathogenesis, epidemiology, functional abnormalities, malignant degeneration, and surgical management. Dysphagia 1993; 8: 276.
Cameron AJ, Ott BJ, Payne WS. The incidence of adenocarcinoma in columnar-lined (Barrett’s) esophagus_ N Engl J Med 1985; 313: 857–9.
Blot WJ, Devesa SS, Kneller RW, et al. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991; 265: 1287–9.
Devesa SS, Blot WJ, Fraumeni JF. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998; 83: 2049–3.
Powell J, McConkey CC. Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites. Br J Cancer 1990; 62: 440–3.
Tuyns AJ. Oesophageal cancer in France and Switzerland:recent time trends. Eur J Cancer Prey 1992; 1: 275–8.
Meller H. Incidence of cancer of the oesophagus, cardia and stomach in Denmark. Eur J Cancer Prey 1992; 1: 159–64.
Hansson L-E, Sparen P, Nyrén O. Increasing incidence of both major histological types of esophageal carcinomas amongst men in Sweden. Tnt J Cancer 1993; 54: 402–7.
Conio M, Aste H, Bonelli L. “Short” Barrett’s esophagus:a condition not to be underestimated. Gastrointest Endosc 1994; 40: 111.
Sharma P, Weston AP, Morales T, Topalowski M, Mayo MS, Sampliner RE. Relative risk of dysplasia for patients with intestinal metaplasia in the distal oesophagus and in the gastric cardia. Gut 2000; 46: 913.
Clark GWB, Smyrk TC, Burdiles P et al. Is Barrett’s metaplasia the source of adenocarcinoma of the cardia? Arch Surg 1994; 129: 609–14.
Iqbal M, Youngberg GA, Young MF, Thomas E. High grade dysplasia/esophageal adenocarcinoma in short segment Barrett’s oesophagus. Southern Med J 1997; 90: 828–30.
Nandurkar S, Martin CJ, Talley NJ, Ma Wyatt J. Curable cancer in a short segment Barrett’s oesophagus. Dis Esophagus 1998; 11: 284–7.
Nishimaki T, Watanabe K, Suzuki T, Hatakeyama K, Watanabe H. Early esophageal adenocarcinoma arising in a short segment of Barrett’s mucosa after total gastrectomy. Am J Gastroenterol 1996; 1856–7.
Siewert JR, Stein HJ. Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 1998;8’5:1457–9.
Siewert JR, Stein HJ. Adenocarcinoma of the gastroesophageal junction. Classification, pathology and extent of resection. Dis Esoph 1996; 9: 173–82.
Robertson CS, Mayberry JF, Nicholson JF et al. Value of endoscopie surveillance in detection of neoplastic change in Barrett’s oesphagus. Br J urg 1988; 75: 760–3.
Hameeteman W, Tytgat GNJ, Huthoff HJ, VanDerTweel JC. Barrett’s esophagus:Development of dysplasia and adenocarcinoma. Gastroenterol 1989; 96: 1249–56.
Miros M, Kerlin P, Walker N. Only patients with dysplasia progress to adenocarcinoma in Barrett’s oesophagus. Gut 1991; 32: 1441–6.
Levine DS, Haggitt RC, Blount PL et al. An endoscopie biopsy protocol can differentiate high grade dysplasia from early adenocarcinoma in Barrett’s esophagus. Gastroenterol 1993; 105: 40–50.
Drewitz DJ, Sampliner RE, Garewal HS. The incidence of adenocarcinoma in Barrett’s esophagus:A prospective study of 170 patients followed 4.8 years. Am J Gastroenterol 1997; 92: 2125.
Weston AP, Krmpotich PT, Cherian R, Dixon A, Topalovski M. Prospective long-term endoscopie and histological follow-up of short segment Barrett’s esophagus:comparison with the traditional long segment Barrett’s esophagus. Am J Gastroenterol 1997(b); 92: 407–13.
Maniatis AG, Brazer SR. Is short segment Barrett’s clinically significant? Am J Gastroenterol 1995; 90: 1894–5.
Sharma P, Morales T, Bhattacharyya A, Garewal HS, Sampliner RE. Dysplasia in of short-segment Barrett’s esophagus:a prospective 3-year follow-up. Am J Gastroenterol 1997; 92: 2012–6.
Romero Y, Riddell RH. Re:Sharma et al. Dysplasia and cancer risk of short-segment Barrett’s esophagus. Am J Gastroenterol 1998; 93: 2639–40.
Kapadia CR. Short-segment Barrett’s esophagus:prevalence, diagnosis, and associations. Gastroenterol 1998; 114: 409–10.
Ireland A, DeMeester TR. Short answer in short segment Barrett’s oesophagus. Gut 1997; 40: 804.
Spechler SJ. The role of gastric carditis in metaplasia and neoplasia at the gastro-esophageal junction. Gastroenterol 1999; 117: 218–28.
Chow WH, Finkle WD, McLauglin JK, Frankl H, Zielk HK, Fraumeni JF Jr. The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia. JAMA 1995; 274: 474–7.
Weinstein WM, Ippoliti AF. The diagnosis of Barrett’s esophagus:goblets, goblets, goblets. Gastrointest Endosc 1996; 44: 91–5.
Cameron AJ, Kamath PS, Carpenter HC. Barrett’s esophagus. The prevalence of short and long segments in reflux patients. Gastroenterol 1996; 108: A65.
Filipe MI, Munoz N, Matko I et al.. Intestinal metaplasia types and the risk of gastric cancer:a cohort study in Slovinia. Int J Cancer 1994; 57: 3249.
Donahue D. Navab F. Significance of short-segment Barrett’s esophagus. Journal of Clinical Gastroenterol. 1997; 25: 480–4.
Weston AP, Krmpotich PT, Cherian R, Dixon A, Topalovski M. Prospective evaluation of intestinal metaplasia and dysplasia within the cardia of patients with Barrett’s esophagus. Dig Dis Sci 1997(a); 42: 597–602.
Hirota WK, Loughney TM, Lazas DJ, Maydonovitch CL, Rholl V, Wong RKH. Specialized intestinal metaplasia, dysplasia, andcancer of the esophagus and esphagogastric junction:prevalence and clinical data. Gastroenterol 1999; 116: 277–85.
Bowrey DJ, Clark GWB, Williams GT. Patterns of gastritis in patients with gastro-esophageal reflux disease. Gut 1999; 45: 798–803.
Riddell RH. The biopsy diagnosis of gastro- esophageal reflux disesase, “carditis”, and Barrett’s esophagus, and sequelae of therapy. Am J Surg Pathol 1996; 20: S31–50.
Oberg S, Peters JH, DeMeester TR et al. Inflammation and specialized intestinal metaplasia of cardiac mucosa is a manifestation of gastroesophageal reflux disease. Ann Surg 1997; 226: 5 2232.
Goldblum JR, Vicari JJ, Falk GW et al. Inflammation and intestinal metaplasia of the gastric cardia:the role of gastro-esophageal reflux and H. pylori infection. Gastroenterol 1998; 114: 633–9.
Hackelsberger A, Gunther T, Schultze V et al. Intestinal metaplasia at the gastro-oesophageal junction:Helicobacter pylori gastritis or gastrooesopageal reflux disease? Gut 1998; 43: 17–21.
Voutilainen M, Fakkila M, Juhola M, Mecklin JP, Sipponen P. Complete and incomplete intestinal metaplasia at the oesophagogastric junction:prevalences and associations with endoscopie erosive oesophagits and gastritis. Gut 1999; 45: 644–8.
Van Dekken H, Geelen E, Dinjens WNM et al. Comparative genomic hybridization of cancer of the gastro-esophageal junction:deletion of 14Q31-32.1 discriminates between esophageal (Barrett’s) and gastric cardia adenocarcinomas. Cancer Res 1999; 59: 748–7.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Preston, S.R., Clark, G.W.B. (2001). Short Segment Barrett’s Esophagus and Intestinal Metaplasia at the Gastroesophageal Junction. In: Tilanus, H.W., Attwood, S.E.A. (eds) Barrett’s Esophagus. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-0829-6_16
Download citation
DOI: https://doi.org/10.1007/978-94-017-0829-6_16
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-5860-7
Online ISBN: 978-94-017-0829-6
eBook Packages: Springer Book Archive